p32 Inhibitor M36

• CAT Number: I019014
• CAS Number: 802555-85-7
• Molecular Formula: C23H28N8O2
• Molecular Weight: 448.52
• Purity: ≥95%
• Synonyms: 1-[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-3-[3-[[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]carbamoylamino]propyl]urea
• InChI: InChI=1S/C23H28N8O2/c32-22(30-18-6-1-4-16(14-18)20-24-10-11-25-20)28-8-3-9-29-23(33)31-19-7-2-5-17(15-19)21-26-12-13-27-21/h1-2,4-7,14-15H,3,8-13H2,(H,24,25)(H,26,27)(H2,28,30,32)(H2,29,31,33)
• InChIKey: HHFOXYBNULCICF-UHFFFAOYSA-N
• SMILES: C1CN=C(N1)C2=CC(=CC=C2)NC(=O)NCCCNC(=O)NC3=CC=CC(=C3)C4=NCCN4

p32 Inhibitor M36（Cat No.:I019014）is a synthetic peptide antagonist designed to block the interaction of p32, a multifunctional protein implicated in tumor progression, angiogenesis, and mitochondrial regulation. By disrupting p32-ligand binding, M36 inhibits tumor cell adhesion, migration, and signaling pathways associated with cancer development. This inhibitor is widely applied in oncology research to explore therapeutic targeting of tumor-specific markers and tumor microenvironment interactions. Its defined sequence and stability make it a valuable tool for investigating p32 biology, cancer progression mechanisms, and the design of novel anti-cancer strategies.